I agree that this site is using cookies. You can find further informations here.
X
Baz, Rachid
173  results:
Search for persons X
?
1

Absolute Lymphocyte Count and Outcomes of Multiple Myeloma ..:

Khouri, Jack ; Dima, Danai ; Li, Hong...
Transplantation and Cellular Therapy.  30 (2024)  8 - p. 790.e1-790.e16 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Evaluation of Outpatient Administration of Ciltacabtagene A..:

Waqar, Syed Hamza Bin ; Hansen, Doris K ; Freeman, Ciara Louise...
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S388 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Simple Score of Albumin and CRP Predicts High-Grade Toxicit..:

Akhtar, Othman S. ; Modi, Karnav ; Kim, Jongphil...
Transplantation and Cellular Therapy.  30 (2024)  3 - p. 283.e1-283.e10 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Idecabtagene Vicleucel (ide-cel) Versus Standard Regimens (..:

Patel, Krina K. ; Rodríguez-Otero, Paula ; Nooka, Ajay K....
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S322 , 2024
Link: https://doi.org/10.1016/..
 
?
5

Safety and efficacy of anti-BCMA CAR-T cell therapy in olde..:

Akhtar, Othman Salim ; Sheeba, Ba Aqeel ; Azad, Farhan...
Journal of Geriatric Oncology.  15 (2024)  2 - p. 101628 , 2024
Link: https://doi.org/10.1016/..
 
?
6

POSTER: MM-059 Incidence and Risk Factors Associated With B..:

Mohammed, Turab ; Peres, Lauren ; Colinleitzinger, Christelle...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S216 , 2023
Link: https://doi.org/10.1016/..
 
?
7

P-213 COVALENT-101: phase I study of BMF-219, a covalent me..:

Rosenberg, Aaron ; Baljevic, Muhamed ; Amor, Adrian Alegre...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S152-S153 , 2023
Link: https://doi.org/10.1016/..
 
?
8

P-031 Idecabtagene vicleucel (ide-cel) vs standard regimens..:

Manier, Salomon ; Rodriguez-Otero, Paula ; Mateos, Maria-Victoria...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S50-S51 , 2023
Link: https://doi.org/10.1016/..
 
?
9

P-012 Safety and efficacy of standard of care (SOC) teclist..:

Grajales-Cruz, Ariel ; Khadka, Sushmita ; Blue, Brandon...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S39-S40 , 2023
Link: https://doi.org/10.1016/..
 
?
10

Anti-BCMA CAR T-Cell Commercial Slot Allocation in Patients..:

Puglianini, Omar Castaneda ; Hansen, Doris K ; Grajales-Cruz, Ariel...
Transplantation and Cellular Therapy.  29 (2023)  2 - p. S217 , 2023
Link: https://doi.org/10.1016/..
 
?
11

MM-059 Incidence and Risk Factors Associated With Bleeding ..:

Mohammed, Turab ; Peres, Lauren ; Colinleitzinger, Christelle...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S473-S474 , 2023
Link: https://doi.org/10.1016/..
 
?
12

Fludarabine Exposure Impact on Safety and Efficacy of Ideca..:

Ionescu, Filip ; Freeman, Ciara ; Castaneda, Omar...
Transplantation and Cellular Therapy.  29 (2023)  2 - p. S188-S189 , 2023
Link: https://doi.org/10.1016/..
 
?
13

P-032 Ide-cel versus standard regimens in patients with tri..:

Manier, Salomon ; Ailawadhi, Sikander ; Rodriguez-Otero, Paula...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S51 , 2023
Link: https://doi.org/10.1016/..
 
?
14

Factors associated with refractoriness or early progression..:

Hashmi, Hamza ; Hansen, Doris K. ; Peres, Lauren C....
Haematologica.  , 2023
Link: https://doi.org/10.3324/..
 
?
15

P866: IDECABTAGENE VICLEUCEL (IDE-CEL) VS STANDARD REGIMENS..:

Manier, Salomon ; Rodríguez-Otero, Paula ; Mateos, Maria-Victoria...
HemaSphere.  7 (2023)  S3 - p. e3385948 , 2023
Link: https://doi.org/10.1097/..
 
1-15